Q-omics provides the consensus-scored MIR6888 profile across patient tissues and cancer cell-line models. MIR6888 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR6888 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, MIR6888 RNA expression shows 4,881 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight KIRC, THCA, and BRCA as cancer lineages where MIR6888 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR6888 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR6888 survival associations across molecular data types. MIR6888 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR6888 RNA expression–survival associations across cancer types. High MIR6888 expression shows unfavorable associations in KIRC, READ, ESCA, LGG, SKCM and BLCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR6888 RNA expression.
This table summarizes MIR6888 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR6888. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR6888 shows higher tumor expression in THCA. The THCA box plot shows higher MIR6888 RNA expression in tumor versus normal tissue (log2 FC = +0.081, t-test p = .013).
This table shows molecular features associated with MIR6888 in patient tissues and cancer cell lines. In patient samples, MIR6888 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.
